Page last updated: 2024-08-25

2-bromopalmitate and Cardiac Hypertrophy

2-bromopalmitate has been researched along with Cardiac Hypertrophy in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dahllöf, B; Edgley, AJ; Lanne, B; Ljung, B; Oakes, ND; Thalén, PG	1
Faccini, JM; Greaves, P; Higgins, AJ	1

Other Studies

2 other study(ies) available for 2-bromopalmitate and Cardiac Hypertrophy

Article	Year
PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats. European journal of pharmacology, 2006, May-24, Volume: 538, Issue:1-3 Topics: Animals; Blood Proteins; Body Weight; Carbon Radioisotopes; Cardiomegaly; Deoxyglucose; Dietary Fats; Dietary Supplements; Epoxy Compounds; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Heart Ventricles; Insulin; Male; Palmitates; PPAR gamma; Propionates; Proteins; Rats; Rats, Wistar; Time Factors; Triglycerides; Tritium	2006
Coronary hyperemia and cardiac hypertrophy following inhibition of fatty acid oxidation. Evidence of a regulatory role for cytosolic phosphorylation potential. Advances in myocardiology, 1985, Volume: 6 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Creatine; Cytosol; Dogs; Fatty Acids; Glycine; Hemodynamics; Isoproterenol; Organ Size; Oxidation-Reduction; Oxygen Consumption; Palmitates; Phosphocreatine; Phosphorylation	1985

Article

Year

PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.

European journal of pharmacology, 2006, May-24, Volume: 538, Issue:1-3

Topics: Animals; Blood Proteins; Body Weight; Carbon Radioisotopes; Cardiomegaly; Deoxyglucose; Dietary Fats; Dietary Supplements; Epoxy Compounds; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Heart Ventricles; Insulin; Male; Palmitates; PPAR gamma; Propionates; Proteins; Rats; Rats, Wistar; Time Factors; Triglycerides; Tritium

2006

Coronary hyperemia and cardiac hypertrophy following inhibition of fatty acid oxidation. Evidence of a regulatory role for cytosolic phosphorylation potential.

Advances in myocardiology, 1985, Volume: 6

Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomegaly; Coronary Circulation; Creatine; Cytosol; Dogs; Fatty Acids; Glycine; Hemodynamics; Isoproterenol; Organ Size; Oxidation-Reduction; Oxygen Consumption; Palmitates; Phosphocreatine; Phosphorylation

1985